2- (4- (quinolin- 2- yl- methoxy)phenyl)- 2- cyclopentylacetic acid
inhibits synthesis of leukotriene B4 and 5-hydroxyeicosatetraenoic acid; inhibits five-lipoxygenase activating protein(FLAP)and leukotriene A4 hydrolase(LTA4H); structure given in first source;
Also Known As:
BAYX-1005; Bay X 1005; Bay X1005; Bay-X1005; DG-031; Veliflapon; Benzeneacetic acid, alpha-cyclopentyl-4-(2-quinolinylmethoxy)-, (R)-
Networked: 12
relevant articles (0 outcomes,
2 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Chan, Su Jing:
1 article
(01/2020)
|
2. | De Foo, Chuan:
1 article
(01/2020)
|
3. | Ng, Geelyn J L:
1 article
(01/2020)
|
4. | Ng, Mary P E:
1 article
(01/2020)
|
5. | Seet, Raymond C S:
1 article
(01/2020)
|
6. | Wong, Peter T-H:
1 article
(01/2020)
|
7. | Zhao, Hui:
1 article
(01/2020)
|
8. | Gajda, M:
1 article
(09/2007)
|
9. | Jawień, J:
1 article
(09/2007)
|
10. | Korbut, R:
1 article
(09/2007)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures